Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Idowu
Ademola David Idowu, Lake Jackson, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090298183 | METHOD AND APPARATUS FOR ANALYZING ARSENIC CONCENTRATIONS USING GAS PHASE OZONE CHEMILUMINESCENCE - A method of detecting arsenic comprising acidifying at least one sample comprising a known arsenic concentration, reducing arsenic in the sample having the known arsenic concentration to arsine, contacting the arsine in the sample having the known arsenic concentration with a reagent to produce a chemiluminescent emission, measuring the intensity of chemiluminescent emission produced by the sample having the known arsenic concentration, acidifying at least one sample comprising an unknown arsenic concentration, reducing arsenic in the sample having the unknown arsenic concentration to arsine, contacting the arsine in the sample having the unknown arsenic concentration with a photoagent to produce a chemiluminescent emission, measuring the intensity of chemiluminescence emission produced by the sample having the unknown arsenic concentration, and determining the arsenic content in the sample having an unknown arsenic concentration by comparing the intensity of chemiluminescent emission of the sample comprising a known arsenic concentration to the chemiluminescent emission of the sample comprising an unknown arsenic concentration, wherein the arsine is not subjected to a low-temperature trap prior to the reaction with a photoagent. | 12-03-2009 |
Michael O. Idowu, Richmond, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110034347 | Signatures Associated with Rejection or Recurrence of Cancer - Methods and tools for assessing the prognosis for patients following treatment of primary tumors are provided. The methods involve identifying immune-related genetic markers whose differential expression patterns at tumor lesions are indicative of either tumor recurrence or recurrence-free survival. The methods and tools of the invention assist physicians by providing objective decision-making tools for planning patient treatment protocols. | 02-10-2011 |
Olajire Idowu, Lodi, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090068332 | Appliance for shucking seed coverings from their kernals - A seed shucking appliance for separating seed coverings from their kernels comprises a vertical cylinder within which is rotated an upward pointing and rotating cone. The top surfaces of the cone and the inside surfaces of the cylinder are roughened to catch and grate the skins or hulls off water-softened beans or grains poured in from above. The clearances and textures between the roughened cone and inside cylinder are such that most of the skins or shells stay above the cone after being knocked loose, and the bared seed kernels drop down through without necessarily being ground up or smashed. What drops through is sent to a water bath where any remaining skins or shells are floated away. The bared seed kernels are drained and ready to be used as whole seed kernels in various kinds of foods. | 03-12-2009 |
Olusola Clement Idowu, Tyne & Wear GB
| Patent application number | Description | Published |
|---|---|---|
| 20110033376 | Treatment of Melanoma - There is described dexanabinol, or a derivative thereof, for the treatment of melanoma. There is also described a method of treating a patient suffering from melanoma. | 02-10-2011 |
Olusola Clement Idowu, Newcastle Upon Tyne GB
| Patent application number | Description | Published |
|---|---|---|
| 20100144626 | Treatment of Multi-Drug Resistant Bacterial Infections - There is described an imidazole for the treatment of an infection caused or contributed to by microorganisms resistant to antibiotics. There is also described a method of treating a patient suffering from an infection caused or contributed to by microorganisms resistant to antibiotics, said method comprising the step of administering an effective amount of an imidazole. | 06-10-2010 |
| 20110020217 | TREATMENT OF MELANOMA - There is described a pharmaceutical composition comprising dexanabinol, or a derivative thereof, in combination with a second therapeutic agent that targets BRAF or MEK, and a pharmaceutically acceptable adjuvant, diluent or carrier. There is also described a method of treating a patient suffering from melanoma and uses related thereto. | 01-27-2011 |
| 20110039906 | ANTIBACTERIAL COMBINATION THERAPY - There is described a composition comprising a therapeutically active imidazole, or a derivative thereof, and disulfiram, or a derivative thereof, for treating an infection contributed to or caused by multi-drug resistant bacterial species. | 02-17-2011 |
Olusola Clement Idowu, Gateshead GB
| Patent application number | Description | Published |
|---|---|---|
| 20090005443 | Treatment of Depression - There is described a compound selected from the group consisting of tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof, for the treatment or alleviation of depression. There is also described a method of treating a patient suffering from depression. | 01-01-2009 |
Olusola Clement Idowu, Bensham GB
| Patent application number | Description | Published |
|---|---|---|
| 20110212173 | Controlled Release Treatment of Depression - There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression. More particularly, there is described an abuse resistant pharmaceutical composition for the treatment of inter alia, depression and controlled release pharmaceutical compositions of related thereto. | 09-01-2011 |